Sociodemographic and Clinical Profile of Cervical Cancer Patients Visiting in a Tertiary Care Hospital in India
Overview
Affiliations
Context: Cancer of the cervix is the most common genital tract malignancy in the female and is a major public health problem in the developing countries. Study of the sociodemographic and clinical profile of patients is the first step in planning control measures and treatment facilities.
Aims: The aims of the study were to determine the sociodemographic and clinical profile of cervical cancer patients and study their association with other tumor-related factors.
Settings And Design: This is a record-based retrospective study from a single institution.
Subjects And Methods: The data on sociodemographic and clinical factors of 765 cervical cancer patients visited and treated at tertiary care cancer hospital in Mumbai in 1 year period were analyzed.
Statistical Analysis: Data were analyzed using descriptive statistics. Kruskal-Wallis and Chi-square test were used to assess relationship between variables.
Results: The median age of the cohort was 54 years and interquartile range was 16 years. Nearly 53.6% of patients were illiterate. About 88.10% of patient's had squamous cell carcinoma. Only 13% of cases had early stage disease and 77% of patient's had not taken any treatment before coming to the hospital. Of the total, about 26% patients also had concomitant comorbidities, of which hypertension was found to be the leading comorbid condition. Stage of disease was found to be significantly ( < 0.05) associated with age and educational status.
Conclusion: This study highlights certain important baseline characteristics of cervical cancer patients. This basic information on profile of patients can help plan and optimum utilization of hospital services, especially in resource-poor countries like India.
Nessa A, Islam T, Noor-E-Ferdousi N, Sultana A, Khan K, Rashid H South Asian J Cancer. 2024; 13(1):17-26.
PMID: 38721107 PMC: 11076093. DOI: 10.1055/s-0043-1776288.
Samaila A, Biambo A, Usman N, Aliyu U, Abdullahi A, Adibe M Afr Health Sci. 2024; 23(3):261-268.
PMID: 38357130 PMC: 10862647. DOI: 10.4314/ahs.v23i3.32.
Increased Gene Expression of Is Associated with Poor Prognosis in Cervical Cancer.
Parida P, Lewis S, Sharan K, Kamal M, Kumar N, Godkhindi V Cells. 2023; 12(21).
PMID: 37947608 PMC: 10649411. DOI: 10.3390/cells12212530.
Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer.
Zhang C, Gu L, Xiao J, Jin F BMC Cancer. 2023; 23(1):684.
PMID: 37474926 PMC: 10360283. DOI: 10.1186/s12885-023-11163-z.
Updates on systemic therapy for cervical cancer.
Gopu P, Antony F, Cyriac S, Karakasis K, Oza A Indian J Med Res. 2022; 154(2):293-302.
PMID: 35295013 PMC: 9131767. DOI: 10.4103/ijmr.IJMR_4454_20.